Adverum Biotechnologies Is Maintained at Sector Perform by RBC Capital

Dow JonesNov 6 00:28 · Ratings

Adverum Biotechnologies Analyst Ratings

BenzingaNov 6 00:17 · Ratings

RBC Capital Initiates Adverum Biotechnologies(ADVM.US) With Hold Rating, Announces Target Price $10

Futu NewsNov 5 21:36 · Ratings

TD Cowen Maintains Adverum Biotechnologies(ADVM.US) With Buy Rating

Futu NewsNov 5 21:36 · Ratings

A Quick Look at Today's Ratings for Adverum Biotechnologies(ADVM.US), With a Forecast Between $10 to $30

Futu NewsNov 5 21:00 · Ratings

Buy Rating on Adverum Biotechnologies Driven by Ixo-vec's Promising Data and Potential Impact on AMD Treatment

TipRanksNov 5 19:25 · Ratings